Metro Healthcare Indonesia Tbk PT
IDX:CARE

Watchlist Manager
Metro Healthcare Indonesia Tbk PT Logo
Metro Healthcare Indonesia Tbk PT
IDX:CARE
Watchlist
Price: 156 IDR 4% Market Closed
Market Cap: 5.2T IDR
Have any thoughts about
Metro Healthcare Indonesia Tbk PT?
Write Note

Intrinsic Value

The intrinsic value of one CARE stock under the Base Case scenario is 13.11 IDR. Compared to the current market price of 156 IDR, Metro Healthcare Indonesia Tbk PT is Overvalued by 92%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CARE Intrinsic Value
13.11 IDR
Overvaluation 92%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Metro Healthcare Indonesia Tbk PT

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CARE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CARE?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Metro Healthcare Indonesia Tbk PT

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Metro Healthcare Indonesia Tbk PT

Provide an overview of the primary business activities
of Metro Healthcare Indonesia Tbk PT.

What unique competitive advantages
does Metro Healthcare Indonesia Tbk PT hold over its rivals?

What risks and challenges
does Metro Healthcare Indonesia Tbk PT face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Metro Healthcare Indonesia Tbk PT.

Provide P/S
for Metro Healthcare Indonesia Tbk PT.

Provide P/E
for Metro Healthcare Indonesia Tbk PT.

Provide P/OCF
for Metro Healthcare Indonesia Tbk PT.

Provide P/FCFE
for Metro Healthcare Indonesia Tbk PT.

Provide P/B
for Metro Healthcare Indonesia Tbk PT.

Provide EV/S
for Metro Healthcare Indonesia Tbk PT.

Provide EV/GP
for Metro Healthcare Indonesia Tbk PT.

Provide EV/EBITDA
for Metro Healthcare Indonesia Tbk PT.

Provide EV/EBIT
for Metro Healthcare Indonesia Tbk PT.

Provide EV/OCF
for Metro Healthcare Indonesia Tbk PT.

Provide EV/FCFF
for Metro Healthcare Indonesia Tbk PT.

Provide EV/IC
for Metro Healthcare Indonesia Tbk PT.

Compare the intrinsic valuations
of Metro Healthcare Indonesia Tbk PT and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Metro Healthcare Indonesia Tbk PT against its competitors.

Analyze the profit margins
(gross, operating, and net) of Metro Healthcare Indonesia Tbk PT compared to its peers.

Compare the P/E ratios
of Metro Healthcare Indonesia Tbk PT against its peers.

Discuss the investment returns and shareholder value creation
comparing Metro Healthcare Indonesia Tbk PT with its peers.

Analyze the financial leverage
of Metro Healthcare Indonesia Tbk PT compared to its main competitors.

Show all profitability ratios
for Metro Healthcare Indonesia Tbk PT.

Provide ROE
for Metro Healthcare Indonesia Tbk PT.

Provide ROA
for Metro Healthcare Indonesia Tbk PT.

Provide ROIC
for Metro Healthcare Indonesia Tbk PT.

Provide ROCE
for Metro Healthcare Indonesia Tbk PT.

Provide Gross Margin
for Metro Healthcare Indonesia Tbk PT.

Provide Operating Margin
for Metro Healthcare Indonesia Tbk PT.

Provide Net Margin
for Metro Healthcare Indonesia Tbk PT.

Provide FCF Margin
for Metro Healthcare Indonesia Tbk PT.

Show all solvency ratios
for Metro Healthcare Indonesia Tbk PT.

Provide D/E Ratio
for Metro Healthcare Indonesia Tbk PT.

Provide D/A Ratio
for Metro Healthcare Indonesia Tbk PT.

Provide Interest Coverage Ratio
for Metro Healthcare Indonesia Tbk PT.

Provide Altman Z-Score Ratio
for Metro Healthcare Indonesia Tbk PT.

Provide Quick Ratio
for Metro Healthcare Indonesia Tbk PT.

Provide Current Ratio
for Metro Healthcare Indonesia Tbk PT.

Provide Cash Ratio
for Metro Healthcare Indonesia Tbk PT.

What is the historical Revenue growth
over the last 5 years for Metro Healthcare Indonesia Tbk PT?

What is the historical Net Income growth
over the last 5 years for Metro Healthcare Indonesia Tbk PT?

What is the current Free Cash Flow
of Metro Healthcare Indonesia Tbk PT?

Discuss the annual earnings per share (EPS)
trend over the past five years for Metro Healthcare Indonesia Tbk PT.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Metro Healthcare Indonesia Tbk PT

Current Assets 720.4B
Cash & Short-Term Investments 673.9B
Receivables 35.8B
Other Current Assets 10.7B
Non-Current Assets 3.3T
PP&E 3.3T
Intangibles 7B
Other Non-Current Assets 4.4B
Current Liabilities 880B
Accounts Payable 17.6B
Accrued Liabilities 25B
Short-Term Debt 794.4B
Other Current Liabilities 43.1B
Non-Current Liabilities 124.5B
Long-Term Debt 115.7B
Other Non-Current Liabilities 8.8B
Efficiency

Earnings Waterfall
Metro Healthcare Indonesia Tbk PT

Revenue
312.9B IDR
Cost of Revenue
-219.5B IDR
Gross Profit
93.4B IDR
Operating Expenses
-133.5B IDR
Operating Income
-40.1B IDR
Other Expenses
-76.1B IDR
Net Income
-116.2B IDR

Free Cash Flow Analysis
Metro Healthcare Indonesia Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CARE Profitability Score
Profitability Due Diligence

Metro Healthcare Indonesia Tbk PT's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive 3-Years Revenue Growth
Declining ROIC
35/100
Profitability
Score

Metro Healthcare Indonesia Tbk PT's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

CARE Solvency Score
Solvency Due Diligence

Metro Healthcare Indonesia Tbk PT's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Positive Net Debt
Short-Term Solvency
46/100
Solvency
Score

Metro Healthcare Indonesia Tbk PT's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CARE Price Targets Summary
Metro Healthcare Indonesia Tbk PT

There are no price targets for CARE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CARE?

Click here to dive deeper.

Dividends

Metro Healthcare Indonesia Tbk PT
does not pay dividends
Shareholder Yield

Current shareholder yield for CARE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Metro Healthcare Indonesia Tbk PT Logo
Metro Healthcare Indonesia Tbk PT

Country

Indonesia

Industry

Health Care

Market Cap

5.2T IDR

Dividend Yield

0%

Description

PT Metro Healthcare Indonesia Tbk engages in the provision of integrated healthcare services. The company is headquartered in Tangerang, Banten and currently employs 713 full-time employees. The company went IPO on 2020-03-13. The firm operates its business in an integrated health service with hospital under Metro Hospital Group. The company is focused on developing technology-based health services and training centers to produce professionals in health services. The firm offers healthcare service with a range of services and facilities including polyclinic, ICU room, class III inpatient room and Super VIP room ready to cater various type of patients. The firm operates RSIA Bunda Sejahtera, RSU Bina Sehat Mandiri, RSU Metro Hospitals Cikarang, RSU Metro Hospitals Cikupa, RSU Kartini, RSIA Mitra Husada, and RSIA Santo Yusuf. Its subsidiaries include PT Metro Global Medika, PT Metro Healthcare Technologies, PT Metro Medika Abadi, PT Mitra Adika Buana, PT Metro Hospitals Indonesia, PT Metro Mitra Sarana, PT Eka Tunggal Jaya, PT Paramudya Dasa Sakti, PT Indah Nusa Indonesia, PT Sejahtera Berkah Berdikari, and PT Berkarya Sejahtera Gemilang.

Contact

BANTEN
Tangerang
Jl. Raya Km 16,8 RT/RW 005/001, Kelurahan Sukamulya, Kecamatan Cikupa, Kabupaten
+622159647937
www.metrohealthcareindonesia.co.id

IPO

2020-03-13

Employees

713

Officers

President Director
Engineer Henry Kembaren M.M.
Finance & Accounting Manager
Dedi A.
HRD Manager
- Evelina
Head of Internal Audit Unit
Irene Octavia
Corporate Secretary & Director
Dr. Dedi Tedjakusnadi
HRD Staff
Debby Sandra

See Also

Discover More
What is the Intrinsic Value of one CARE stock?

The intrinsic value of one CARE stock under the Base Case scenario is 13.11 IDR.

Is CARE stock undervalued or overvalued?

Compared to the current market price of 156 IDR, Metro Healthcare Indonesia Tbk PT is Overvalued by 92%.

Back to Top